TwinStrand Biosciences Says Delaware Court Entered Final Judgment Awarding More Than $245.2M Against Guardant Health, Orders 6% Royalty On 11 Products Through Patent Expiration March 15, 2033

뉴스 본문을 불러오고 있어요.

TwinStrand Biosciences Says Delaware Court Entered Final Judgment Awarding More Than $245.2M Against Guardant Health, Orders 6% Royalty On 11 Products Through Patent Expiration March 15, 2033 | 웨이프 WAPE

TwinStrand Biosciences Says Delaware Court Entered Final Judgment Awarding More Than $245.2M Against Guardant Health, Orders 6% Royalty On 11 Products Through Patent Expiration March 15, 2033

기사 요약

관련 종목

댓글 —